GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
78 hedge funds and large institutions have $516M invested in GenMark Diagnostics, Inc in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 8 closing their positions.
84% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 19
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
9% more capital invested
Capital invested by funds: $474M → $516M (+$42M)
7% more funds holding
Funds holding: 73 → 78 (+5)
18% less call options, than puts
Call options by funds: $9K | Put options by funds: $11K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$5.62M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$4.42M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.94M |
| 4 |
CCM
Cadian Capital Management
New York
|
+$3.89M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.9M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.89M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.11M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.14M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$2.15M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
BNP Paribas Financial Markets
Paris,
France
| $6.18K | +$5.63K | +464 | New |
|
77
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5.87K | +$263K | +21,655 | +5% |
|
78
Creative Planning
Overland Park,
Kansas
| $4K | +$3.64K | +300 | New |
|
|
PHS
79
PFM Health Sciences
San Francisco,
California
| – | -$7.89M | -650,015 | Closed |
|
|
80
Citadel Advisors
Miami,
Florida
| – | -$5.11M | -420,401 | Closed |
|
|
KIA
81
Kopp Investment Advisors
Bloomington,
Minnesota
| – | -$992K | -81,708 | Closed |
|
82
ProShare Advisors
Bethesda,
Maryland
| – | -$275K | -22,644 | Closed |
|
|
PIM
83
Partner Investment Management
San Francisco,
California
| – | -$242K | -19,968 | Closed |
|
84
Invesco
Atlanta,
Georgia
| – | -$149K | -12,305 | Closed |
|
85
Group One Trading
Chicago,
Illinois
| – | -$27.3K | -2,250 | Closed |
|
|
RFC
86
Russell Frank Company
Seattle,
Washington
| – | -$2K | -155 | Closed |
|
GNMK Hedge Fund Activity: Q4 2013 in Review
78 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2013, worth a combined $516M — up 8.9% from $474M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new GNMK positions and 8 closed out — a net gain of 5 holders — while 35 added to existing stakes and 19 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $5.62M. The largest seller was T. Rowe Price Associates, cutting an estimated $18.9M.
- 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2013, up from 73 in Q3 2013.
- Funds reported $516M of GenMark Diagnostics, Inc stock for Q4 2013, up 8.9% quarter-over-quarter.
- 13 funds opened new GenMark Diagnostics, Inc positions in Q4 2013 and 8 closed out, a net change of +5 holders.
- The largest GenMark Diagnostics, Inc buyer in Q4 2013 was JP Morgan Chase, an estimated $5.62M added.
- The largest GenMark Diagnostics, Inc seller in Q4 2013 was T. Rowe Price Associates, an estimated $18.9M sold.
Based on aggregated 13F filings for Q4 2013.